Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

NCT06110130 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

FED

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

Washington D.C. Veterans Affairs Medical Center

Collaborators

[object Object]